February 24, 2019
Mylan (NSDQ:MYL) said today that it launched its buprenorphine and naloxone sublingual film as a generic of Indivior‘s (LON:INDV) Suboxone sublingual film. The product is indicated for the treatment of opioid dependence. The therapy should be used alongside counseling and psychosocial support for people living with opioid dependence, according to Mylan. Get the full story at our […]
Read the full article →
February 24, 2019
HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2019 — (Healthcare Sales & Marketing Network) — Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 m… Biopharmaceuticals, Drug Delivery, Generics, Product Launch Mylan, Buprenorphine, Naloxone, Suboxone, Sublingual (Source: HSMN NewsFeed) MedWorm Message: […]
Read the full article →